GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Total Stockholders Equity

Genomtec (WAR:GMT) Total Stockholders Equity : zł8.30 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec Total Stockholders Equity?

Genomtec's Total Stockholders Equity for the quarter that ended in Dec. 2023 was zł8.30 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genomtec's Book Value per Share for the quarter that ended in Dec. 2023 was zł0.68. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genomtec's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.24.


Genomtec Total Stockholders Equity Historical Data

The historical data trend for Genomtec's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Total Stockholders Equity Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 1.09 7.57 0.72 4.89 8.30

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.89 2.81 13.22 10.51 8.30

Genomtec  (WAR:GMT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genomtec's Book Value per Share for the quarter that ended in Dec. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genomtec's Debt-to-Equity for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomtec Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genomtec's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomtec (WAR:GMT) Business Description

Traded in Other Exchanges
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines